Atlas Trials

Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism

Clinical trial NCT03773172 · TERMINATED

Trial details

NCT number
NCT03773172
Sponsor
Columbia University
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Cardiovascular Diseases
Start date
2019-01-31
Primary completion
2020-08-31
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.